Novo Integrated Sciences, Inc. Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect in USD from Q4 2018 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
Novo Integrated Sciences, Inc. quarterly/annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect history and growth rate from Q4 2018 to Q4 2023.
  • Novo Integrated Sciences, Inc. Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for the quarter ending November 30, 2023 was $1.22M.
  • Novo Integrated Sciences, Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2023 was -$1.76M, a 71.2% increase from 2022.
  • Novo Integrated Sciences, Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2022 was -$6.11M, a 198% decline from 2021.
  • Novo Integrated Sciences, Inc. annual Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect for 2021 was $6.23M.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $1.22M +$2.52M Sep 1, 2023 Nov 30, 2023 10-Q 2024-01-22
Q4 2022 -$1.3M -$1.81M -356% Sep 1, 2022 Nov 30, 2022 10-Q 2024-01-22
Q4 2021 $508K +$605K Sep 1, 2021 Nov 30, 2021 10-Q 2023-05-24
Q4 2020 -$97.3K +$54.6K +36% Sep 1, 2020 Nov 30, 2020 10-Q 2022-01-18
Q4 2019 -$152K -$405K -160% Sep 1, 2019 Nov 30, 2019 10-Q 2021-01-13
Q4 2018 $253K Sep 1, 2018 Nov 30, 2018 10-Q 2020-01-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.